Archive Picks

More from 2004


News Briefs: July 01, 2004

The morning-after pill, persecution in Vietnam, and the Jesus Video Project.
2004This article is part of CT's digital archives. Subscribers have access to all current and past issues, dating back to 1956.
Plan B: Under the Counter

In a surprise decision, the Food and Drug Administration (FDA) announced on May 6 that it would not allow the "morning-after pill" to be sold over the counter (CT, April, p. 21). The FDA, in rejecting the recommendation of two of its advisory committees, said teenagers might not use the drug safely without the guidance of a physician. Pro-life advocates say the drug, also called Plan B, can cause abortions by blocking implantation of an embryo.

251 Massacred

Vietnam continues persecuting Christians and others in the country's Central Highlands. According to International Christian Concern, Vietnamese authorities have massacred 251 people in nine villages, and the death toll may go higher. The government has cracked down on Montagnards, who are largely Christian, after demonstrations in 2001 for greater religious freedom and against seizure of their lands. More than 200 Montagnards died in attacks over the Easter weekend.

Jesus in Every Home

The Jesus Video Project America is seeking to distribute copies of the Jesus video to all 75 million homes in the United States by 2010. So far, the ministry has placed videos in 20 million homes. Distribution in three states—Hawaii, South Carolina, and Alabama—is done. The organization ( has just released an expanded-content DVD.

Related Elsewhere:

Christianity Today articles on the morning-after pill include:

Weblog: FDA Panel Recommends Over-the-counter 'Morning After' Pill (Dec. 17, 2003)
Plan B (for Bad) | Christians fight to keep 'morning-after pill' under the counter. (March 10, 2004)
Mourning the Morning-After Pill | Ever since the introduction of the birth-control pill, "liberated" Americans have hankered after still more spontaneity: they ...
Subscriber access only You have reached the end of this Article Preview

To continue reading, subscribe now. Subscribers have full digital access.

From Issue:
Subscribe to CT and get one year free.
More from this IssueRead This Issue
Read These Next